» Articles » PMID: 26391104

Interleukin 10 and Dendritic Cells Are the Main Suppression Mediators of Regulatory T Cells in Human Neurocysticercosis

Overview
Date 2015 Sep 23
PMID 26391104
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Neurocysticercosis is caused by the establishment of Taenia solium cysticerci in the central nervous system. It is considered that, during co-evolution, the parasite developed strategies to modulate the host's immune response. The action mechanisms of regulatory T cells in controlling the immune response in neurocysticercosis are studied in this work. Higher blood levels of regulatory T cells with CD4(+) CD45RO(+) forkhead box protein 3 (FoxP3)(high) and CD4(+) CD25(high) FoxP3(+) CD95(high) phenotype and of non-regulatory CD4(+) CD45RO(+) FoxP3(med) T cells were found in neurocysticercosis patients with respect to controls. Interestingly, regulatory T cells express higher levels of cytotoxic T lymphocyte antigen 4 (CTLA-4), lymphocyte-activation gene 3 (LAG-3), programmed death 1 (PD-1) and glucocorticoid-induced tumour necrosis factor receptor (GITR), suggesting a cell-to-cell contact mechanism with dendritic cells. Furthermore, higher IL-10 and regulatory T cell type 1 (Tr1) levels were found in neurocysticercosis patients' peripheral blood, suggesting that the action mechanism of regulatory T cells involves the release of immunomodulatory cytokines. No evidence was found of the regulatory T cell role in inhibiting the proliferative response. Suppressive regulatory T cells from neurocysticercosis patients correlated negatively with late activated lymphocytes (CD4(+) CD38(+) ). Our results suggest that, during neurocysticercosis, regulatory T cells could control the immune response, probably by a cell-to-cell contact with dendritic cells and interleukin (IL)-10 release by Tr1, to create an immunomodulatory environment that may favour the development of T. solium cysticerci and their permanence in the central nervous system.

Citing Articles

Immunologic Profiling of CSF in Subarachnoid Neurocysticercosis Reveals Specific Interleukin-10-Producing Cell Populations During Treatment.

Tang N, Schaughency P, Gazzinelli-Guimaraes P, Lack J, Thumm L, Miltenberger E Neurol Neuroimmunol Neuroinflamm. 2024; 11(6):e200320.

PMID: 39475624 PMC: 11527482. DOI: 10.1212/NXI.0000000000200320.


Regulatory T cells modulate monocyte functions in immunocompetent antiretroviral therapy naive HIV-1 infected people.

Georgia A, Claudine N, Carole S, Loveline N, Abel L, Flaurent T BMC Immunol. 2024; 25(1):68.

PMID: 39402453 PMC: 11472541. DOI: 10.1186/s12865-024-00654-8.


Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson's disease: a 1-year observational study.

Arce-Sillas A, Alvarez-Luquin D, Leyva-Hernandez J, Montes-Moratilla E, Vivas-Almazan V, Perez-Correa C J Neural Transm (Vienna). 2024; 131(8):901-916.

PMID: 38822829 DOI: 10.1007/s00702-024-02790-2.


Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?.

Toledo A, Fragoso G, Carrillo-Mezo R, Romo M, Sciutto E, Fleury A Pathogens. 2023; 12(9).

PMID: 37764924 PMC: 10535301. DOI: 10.3390/pathogens12091116.


Standardizing an Experimental Murine Model of Extraparenchymal Neurocysticercosis That Immunologically Resembles Human Infection.

Espinosa-Ceron A, Mendez A, Hernandez-Aceves J, Juarez-Gonzalez J, Villalobos N, Hernandez M Brain Sci. 2023; 13(7).

PMID: 37508953 PMC: 10377049. DOI: 10.3390/brainsci13071021.


References
1.
Sciutto E, Fragoso G, Fleury A, Laclette J, Sotelo J, Aluja A . Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect. 2001; 2(15):1875-90. DOI: 10.1016/s1286-4579(00)01336-8. View

2.
Bonney K, Taylor J, Thorp E, Epting C, Engman D . Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease. Parasitol Res. 2015; 114(3):1167-78. PMC: 4336812. DOI: 10.1007/s00436-014-4300-3. View

3.
Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299(5609):1057-61. DOI: 10.1126/science.1079490. View

4.
Yu K, Kim H, Song S, Min S, Jeong J, Youn B . Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem Biophys Res Commun. 2003; 310(2):433-8. DOI: 10.1016/j.bbrc.2003.09.024. View

5.
Walther M, Tongren J, Andrews L, Korbel D, King E, Fletcher H . Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 2005; 23(3):287-96. DOI: 10.1016/j.immuni.2005.08.006. View